Clinical use of polyvalent immunoglobulins
- PMID: 24333311
- PMCID: PMC3853978
- DOI: 10.2450/2013.007s
Clinical use of polyvalent immunoglobulins
Figures

Similar articles
-
Polyvalent immunoglobulins: challenges and perspectives.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s40-4. doi: 10.2450/2013.008s. Blood Transfus. 2013. PMID: 24333312 Free PMC article. Review. No abstract available.
-
The demand for polyvalent immunoglobulins in Italy.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s45-54. doi: 10.2450/2013.009s. Blood Transfus. 2013. PMID: 24333313 Free PMC article. Review. No abstract available.
-
Immunoglobulin therapy: methods of delivery.J Allergy Clin Immunol. 2008 Nov;122(5):1038-9. doi: 10.1016/j.jaci.2008.08.012. Epub 2008 Sep 19. J Allergy Clin Immunol. 2008. PMID: 18804269 No abstract available.
-
Immunoglobulins and sepsis.Intensive Care Med. 2018 Nov;44(11):1923-1925. doi: 10.1007/s00134-018-5047-6. Epub 2018 Jan 18. Intensive Care Med. 2018. PMID: 29349688 Review. No abstract available.
-
Calling time on intravenous immunoglobulin for preterm infants?Cochrane Database Syst Rev. 2013 Jul 19;2013(7):ED000062. doi: 10.1002/14651858.ED000062. Cochrane Database Syst Rev. 2013. PMID: 24151648 Free PMC article. No abstract available.
Cited by
-
Plasma-derived medicinal products: demand and clinical use.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s2-5. doi: 10.2450/2013.002s. Blood Transfus. 2013. PMID: 24333309 Free PMC article. No abstract available.
-
Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection.Front Public Health. 2022 May 19;10:893770. doi: 10.3389/fpubh.2022.893770. eCollection 2022. Front Public Health. 2022. PMID: 35664094 Free PMC article.
-
The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.Blood Transfus. 2019 Nov;17(6):449-458. doi: 10.2450/2019.0265-19. Epub 2019 Dec 11. Blood Transfus. 2019. PMID: 31846609 Free PMC article. Review.
-
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.Immunol Res. 2015 Mar;61(3):326-37. doi: 10.1007/s12026-014-8615-z. Immunol Res. 2015. PMID: 25550086 Review.
References
-
- Provan D, Chapel HM, Sewell WA, O’Shaughnessy D. Prescribing intravenous immunoglobulin: summary of Department of Health guidelines. BMJ. 2008;337:a1831. - PubMed
-
- Delforge M, Farber CM, Spath P, et al. Recommended indications for the administration of polyclonal immunoglobulin preparations. Acta Clin Belg. 2011;66:346–60. - PubMed
-
- O’Shaughnessy D, editor. Third National Immunoglobulin Database Report (2012) Manchester: Medical Data Services and Solutions; 2013. [Accessed on 11/09/2013]. Available at: http://www.ivig.nhs.uk/documents/Third_National_Immunoglobulin_Database_....
-
- Orange JS, Hossny EM, Weiler CR. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117:S525–53. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources